Acute augmentation of serotonin suppresses cardiovascular responses to emotional valence

International Journal of Neuropsychopharmacology

Volumn 7, Issue 1, 2004, Pages 65-70

  Kemp, Andrew H ^a   Nathan, Pradeep J ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Antidepressants; Cardiovascular system; Citalopram; Emotional valence; Heart rate; Serotonin

Indexed keywords

CITALOPRAM; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; EMOTION; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL;

ADULT; AROUSAL; CITALOPRAM; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HEART RATE; HUMANS; MALE; PHOTIC STIMULATION; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 1942475393     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145703003894     Document Type: Article

References (26)

1. Aftanas L, Varlamov A, Pavlov S, Makhnev V, Reva N (2001). Event-related synchronization and desynchronization during affective processing: emergence of valence-related time-dependent hemispheric asymmetries in theta and upper alpha band. International Journal of Neuroscience 110, 197-219.
2. Agewall S, Wikstrand J, Dahlof C, Fagerberg B (1996). Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk. American Journal of Hypertension 9, 545-550.
3. Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152.
4. Bernston GG, Cacioppo JT, Karen S (1991). Autonomic determinism: the modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint. Psychological Science 98, 459-487.
5. Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW (2002). Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berlin) 160, 353-361.
6. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, Czajkowski SM, O'Connor C, Stone PH, Freedland KE (2001). Depression, heart rate variability, and acute myocardial infarction. Circulation 104, 2024-2028.
7. James W (1884). What is an emotion? Mind 9, 188-205.
8. Jones BJ, Blackburn TP (2002). The medical benefit of 5-HT research. Pharmacology, Biochemistry, and Behavior 71, 555-568.
9. Kemp AH, Gray MA, Eide P, Silberstein RB, Nathan PJ (2002). Steady-state visually evoked potential topography during processing of emotional valence in healthy subjects. NeuroImage 17, 1684-1692.
10. Lane RD, Reiman EM, Ahern GL, Thayer JF (2001). Activity in medial prefrontal cortex correlates with vagal compmonent of heart rate variability during emotion. Brain Cognition 47, 97-100.
11. Lang PJ, Greenwald MK, Bradley MM, Hamm AO (1993). Looking at pictures-affective, facial, visceral, and behavioral reactions. Psychophysiology 30, 261-273.
12. Loewy AD, McKellar S (1980). The neuroanatomical basis of central cardiovascular control. Federation Proceedings 39, 2495-2503.
13. Nathan PJ, Norman TR, Burrows GD (1996). Nocturnal plasma melatonin concentrations in healthy volunteers: effect of single doses of d-fenfluramine, paroxetine, and ipsapirone. Journal of Pineal Research 21, 55-58.
14. Noble S, Benfield P (1997). Citalopram: a review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs 8, 410-431.
15. Palomba D, Angrilli A, Mini A (1997). Visual evoked potentials, heart rate responses and memory to emotional pictorial stimuli. International Journal of Psychophysiology 27, 55-67.
16. Rasmussen SL, Overo KF, Tanghoj P (1999). Cardiac safety of citalopram: prospective trials and retrospective analyses. Journal of Clinical Psychopharmacology 19, 407-415.
17. Richardson JS, Chiu EK (1983). The regulation of cardiovascular functions by monoamine neurotransmitters in the brain. International Journal of Neuroscience 20, 103-148.
18. Roose SP (2001). Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective. Journal of Clinical Psychiatry 62, 19-22.
19. Sakuragi S, Sugiyama Y, Takeuchi K (2002). Effects of laughing and weeping on mood and HR. Journal of Physiological Anthropology and Applied Human Science 21, 159-165.
20. Sheps DS, Sheffield D (2001). Depression, anxiety, and the cardiovascular system: the cardiologist's perspective. Journal of Clinical Psychiatry 62, 12-16.
21. Stein PK, Kleiger RE (1999). Insights from the study of HR. Annual Review of Medicine 50, 249-261.
22. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93, 1043-1065.
23. Thayer JF, Siegle GJ (2002). Neurovisceral integration in cardiac and emotional regulation. IEEE Engineering in Medicine and Biology Magazine 21, 24-29.
24. Yeragani VK (2000). Major depression and long-term heart period variability. Depression and Anxiety 12, 51-52.
25. Yeragani VK, Pesce V, Jayaraman A, Roose S (2002a). Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biological Psychiatry 52, 418-429.
26. Yeragani VK, Rao KA, Smitha MR, Pohl RB, Balon R, Srinivasan K (2002b). Diminished chaos of heart rate time series in patients with major depression. Biological Psychiatry 51, 733-744.